Literature DB >> 2411017

Interaction of brevetoxin A with a new receptor site on the sodium channel.

W A Catterall, M Gainer.   

Abstract

Measurements of neurotoxin-activated 22Na influx in neuroblastoma cells and neurotoxin binding in synaptosomes were used to define the site and mechanism of action of brevetoxins on sodium channels. Brevetoxin A alone did not enhance the sodium permeability of neuroblastoma cells, but markedly enhanced persistent activation of sodium channels by veratridine, aconitine and batrachotoxin, which act at neurotoxin receptor site 2. Enhancement of batrachotoxin action was accompanied by a 4.3-fold increase in the binding of [3H]batrachotoxinin A 20-alpha-benzoate to receptor site 2 on sodium channels in synaptosomes. These results point to an allosteric mechanism of brevetoxin action involving preferential binding to active states of sodium channels which have high affinity for neurotoxins, causing persistent activation of sodium channels at receptor site 2. Brevetoxin A does not block [3H]saxitoxin binding at neurotoxin receptor site 1 or 125I-labeled scorpion toxin binding at neurotoxin receptor site 3. The brevetoxins appear to act at a new neurotoxin receptor site on the sodium channel.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2411017     DOI: 10.1016/0041-0101(85)90034-0

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  11 in total

Review 1.  Sodium channel toxins and neurotransmitter release.

Authors:  André Ricardo Massensini; Marco Aurélio Romano-Silva; Marcus Vinícius Gomez
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

2.  Bidirectional influence of sodium channel activation on NMDA receptor-dependent cerebrocortical neuron structural plasticity.

Authors:  Joju George; Daniel G Baden; William H Gerwick; Thomas F Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

3.  Pumiliotoxin B binds to a site on the voltage-dependent sodium channel that is allosterically coupled to other binding sites.

Authors:  F Gusovsky; D P Rossignol; E T McNeal; J W Daly
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Brevetoxin-induced neural insult in the retrosplenial cortex of mouse brain.

Authors:  Xiuzhen Yan; Janet M Benson; Andrea P Gomez; Daniel G Baden; Thomas F Murray
Journal:  Inhal Toxicol       Date:  2006-12       Impact factor: 2.724

5.  Antillatoxin is a marine cyanobacterial toxin that potently activates voltage-gated sodium channels.

Authors:  W I Li; F W Berman; T Okino; F Yokokawa; T Shioiri; W H Gerwick; T F Murray
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Inhibition by propofol of [3H]-batrachotoxinin-A 20-alpha-benzoate binding to voltage-dependent sodium channels in rat cortical synaptosomes.

Authors:  L Ratnakumari; H C Hemmings
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  Sodium channel activation augments NMDA receptor function and promotes neurite outgrowth in immature cerebrocortical neurons.

Authors:  Joju George; Shashank M Dravid; Anand Prakash; Jun Xie; Jennifer Peterson; Sairam V Jabba; Daniel G Baden; Thomas F Murray
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

8.  Characterization of [3H]brevetoxin binding to voltage-dependent sodium channels in adrenal medullary cells.

Authors:  T Yuhi; A Wada; R Yamamoto; M Urabe; H Niina; F Izumi; T Yanagita
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

9.  Reserpine: interactions with batrachotoxin and brevetoxin sites on voltage-dependent sodium channels.

Authors:  Andrew Flowers; Kenolisa Onwueme; Cyrus R Creveling; John W Daly
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

Review 10.  Biotechnological and Pharmacological Applications of Biotoxins and Other Bioactive Molecules from Dinoflagellates.

Authors:  Joana Assunção; A Catarina Guedes; F Xavier Malcata
Journal:  Mar Drugs       Date:  2017-12-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.